276 related articles for article (PubMed ID: 28383433)
61. The expression of ALDH1 in cervical carcinoma.
Yao T; Chen Q; Zhang B; Zhou H; Lin Z
Med Sci Monit; 2011 Aug; 17(8):HY21-26. PubMed ID: 21804471
[TBL] [Abstract][Full Text] [Related]
62. Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.
Lohberger B; Rinner B; Stuendl N; Absenger M; Liegl-Atzwanger B; Walzer SM; Windhager R; Leithner A
PLoS One; 2012; 7(8):e43664. PubMed ID: 22928012
[TBL] [Abstract][Full Text] [Related]
63. Association of aldehyde dehydrogenase 1 expression and biologically aggressive features in breast cancer.
Kang EJ; Jung H; Woo OH; Park KH; Woo SU; Yang DS; Kim AR; Lee JB; Kim YH; Kim JS; Seo JH
Neoplasma; 2014; 61(3):352-62. PubMed ID: 24824938
[TBL] [Abstract][Full Text] [Related]
64. Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma.
Mansour SF; Atwa MM
Asian Pac J Cancer Prev; 2015; 16(17):7491-6. PubMed ID: 26625750
[TBL] [Abstract][Full Text] [Related]
65. Aldehyde dehydrogenase 1-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node-positive breast cancer.
Sakakibara M; Fujimori T; Miyoshi T; Nagashima T; Fujimoto H; Suzuki HT; Ohki Y; Fushimi K; Yokomizo J; Nakatani Y; Miyazaki M
Cancer; 2012 Aug; 118(16):3899-910. PubMed ID: 22180194
[TBL] [Abstract][Full Text] [Related]
66. Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer.
Pan H; Wu N; Huang Y; Li Q; Liu C; Liang M; Zhou W; Liu X; Wang S
Diagn Pathol; 2015 Jun; 10():66. PubMed ID: 26070788
[TBL] [Abstract][Full Text] [Related]
67. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
[TBL] [Abstract][Full Text] [Related]
68. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
[TBL] [Abstract][Full Text] [Related]
69. Characterization of CD44+ALDH1+Ki-67- Cells in Non-malignant and Neoplastic Lesions of the Breast.
DA Cruz Paula A; Marques O; Sampaio R; Rosa A; Garcia J; Rêma A; DE Fátima Faria M; Silva P; Vizcaíno R; Lopes C
Anticancer Res; 2016 Sep; 36(9):4629-38. PubMed ID: 27630305
[TBL] [Abstract][Full Text] [Related]
70. Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.
Kim YJ; Sung M; Oh E; Vrancken MV; Song JY; Jung K; Choi YL
Cancer Biol Ther; 2018 Apr; 19(4):335-345. PubMed ID: 29333926
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.
Zhu B; Zhou L; Yu L; Wu S; Song W; Gong X; Wang D
BMC Surg; 2017 Apr; 17(1):47. PubMed ID: 28431527
[TBL] [Abstract][Full Text] [Related]
72. Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells.
Gehlot P; Shukla V; Gupta S; Makidon PE
J Transl Med; 2016 Feb; 14():49. PubMed ID: 26873175
[TBL] [Abstract][Full Text] [Related]
73. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma.
Luo WR; Yao KT
Virchows Arch; 2014 Jan; 464(1):35-43. PubMed ID: 24248285
[TBL] [Abstract][Full Text] [Related]
74. ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status.
Qian X; Wagner S; Ma C; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
Oncol Rep; 2013 May; 29(5):1777-84. PubMed ID: 23483187
[TBL] [Abstract][Full Text] [Related]
75. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Jiang F; Qiu Q; Khanna A; Todd NW; Deepak J; Xing L; Wang H; Liu Z; Su Y; Stass SA; Katz RL
Mol Cancer Res; 2009 Mar; 7(3):330-8. PubMed ID: 19276181
[TBL] [Abstract][Full Text] [Related]
76. Clinical implication of leucine zipper/EF hand-containing transmembrane-1 overexpression in the prognosis of triple-negative breast cancer.
Wang CA; Liu Q; Chen Y; Liu S; Xu J; Cui X; Zhang Y; Piao L
Exp Mol Pathol; 2015 Apr; 98(2):254-9. PubMed ID: 25617527
[TBL] [Abstract][Full Text] [Related]
77. ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer.
Oh SY; Sohn SH; Yim H; Lee D; Suh KW; Kim YB
J Surg Oncol; 2015 Feb; 111(2):243-7. PubMed ID: 25270363
[TBL] [Abstract][Full Text] [Related]
78. Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
Louhichi T; Ziadi S; Saad H; Dhiab MB; Mestiri S; Trimeche M
Breast Cancer; 2018 Nov; 25(6):698-705. PubMed ID: 29845398
[TBL] [Abstract][Full Text] [Related]
79. High Expression of
Ozaki A; Motomura H; Tamori S; Onaga C; Nagashima Y; Kotori M; Matsuda C; Matsuda A; Mochizuki N; Sato T; Hara Y; Sato K; Miyagi Y; Nagashima Y; Hanawa T; Harada Y; Xiong Y; Sasaki K; Ohno S; Akimoto K
Anticancer Res; 2022 Jul; 42(7):3299-3312. PubMed ID: 35790283
[TBL] [Abstract][Full Text] [Related]
80. Expression of aldehyde dehydrogenase 1 in colon cancer.
Hou Y; Liu YY; Zhao XK
Asian Pac J Trop Med; 2013 Jul; 6(7):574-7. PubMed ID: 23768832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]